Diana Roy, DO
Family Practice · Plano, TXNPI 1609403047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Among family practice clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$316
- AbbVie$197
- AstraZeneca$197
- Exact Sciences$77
- Lilly USA, LLC$63
- Boehringer Ingelheim$63
- plus $522 from 16 others
What the payments were for
- Food & beverage$1,437100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $316 |
| AbbVie | 13 | $197 |
| AstraZeneca | 13 | $197 |
| Exact Sciences | 3 | $77 |
| Lilly USA, LLC | 4 | $63 |
| Boehringer Ingelheim | 3 | $63 |
| Johnson & Johnson | 3 | $57 |
| Bayer | 3 | $55 |
| Eisai Inc. | 2 | $54 |
| Astellas Pharma US Inc | 3 | $50 |
| Dexcom, Inc. | 3 | $45 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Antares Pharma, Inc. | 2 | $37 |
| GSK | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Organon | 2 | $23 |
| Recor Medical Inc | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $18 |
| Pfizer | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
How this compares
$1,437 in reported general payments places this provider in the 95th percentile of 646 family practice providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $16,540 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $6,005 |
| JardianceEmpagliflozin | 11 | $5,507 |
| SynthroidLevothyroxine Sodium | 12 | $574 |
| Rosuvastatin Calcium | 58 | $497 |
| Atorvastatin Calcium | 66 | $359 |
| Metoprolol Succinate | 24 | $328 |
| Levothyroxine Sodium | 54 | $307 |
| Lisinopril | 63 | $288 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $283 |
| Losartan Potassium | 36 | $262 |
| Trazodone Hcl | 32 | $259 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $249 |
| Duloxetine Hcl | 11 | $213 |
| Buspirone Hcl | 14 | $201 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $16,54016 claims |
| GSKBreo Ellipta | $29 | $6,00513 claims |
| Boehringer IngelheimJardiance | $63 | $5,50711 claims |
| AbbVieSynthroid | $197 | $57412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 646 family practice providers in Texas.
Other family practice in Plano
- Christopher EliasPlano$751
- Lorenzo PerezPlano$0
- Mark RobbinsSchertz$99K
- Lena BruceSanta Fe$8K
- Akhila ReddyHouston$7K
- William CalleyGarland$7K
- Leticia Arredondo CerdaSan Antonio$7K
- Thomas SeymourConroe$6K
- Adolat MirzaevaHouston$5K
- Pedro YenMesquite$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.